Use of Dalfampridine in Primary Lateral Sclerosis

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

Motor Neuron Disease, Upper

Interventions

DRUG

dalfampridine

Pill open label

Trial Locations (3)

Shara Holzberg, New York

University of Florida Gainsville, Gainesville

Mass General Hospital, Boston

All Listed Sponsors

lead

Hospital for Special Surgery, New York

OTHER